| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9925282 | The American Journal of Geriatric Pharmacotherapy | 2005 | 10 Pages |
Abstract
From a public payer's perspective, the observed effect of memantine on cognitive and physical function is predicted to translate into economic benefits that offset the added treatment cost. Treatment is also predicted to delay institutionalization, improve independence, and increase QALYs.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
MD, MSc, PhD Jönsson,